Last updated on August 2018

A Safety and Dose-Finding Study of SYNT001 in Subjects With Pemphigus (Vulgaris or Foliaceus)


Brief description of study

This is a multicenter, open-label safety study to determine the dose regimen of SYNT001 administered intravenously in subjects with pemphigus (vulgaris or foliaceus).

Clinical Study Identifier: NCT03075904

Find a site near you

Start Over

Syntimmune Study Site

Cleveland, OH United States
6.32miles
  Connect »